Oral Delivery of Pterostilbene by L-Arginine-Mediated “Nano-Bomb” Carrier for the Treatment of Ulcerative Colitis

References

• Ungaro R, Colombel JF, Lissoos T, Peyrin-Biroulet L. A treat-to-target update in ulcerative colitis: a systematic review. Am J Gastroenterol. 2019;114(6):874–883. doi:10.14309/ajg.0000000000000183
   PubMed Web of Science ®Google Scholar
• Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114(3):384–413.
   PubMed Web of Science ®Google Scholar
• Hartwig O, Shetab Boushehri MA, Shalaby KS, Loretz B, Lamprecht A, Lehr CM. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Adv Drug Deliv Rev. 2021;175:113828.
   PubMed Web of Science ®Google Scholar
• Zheng K, Jia J, Yan S, Shen H, Zhu P, Yu J. Paeoniflorin ameliorates ulcerative colitis by modulating the dendritic cell-mediated TH17/Treg balance. Inflammopharmacology. 2020;28(6):1705–1716.
   PubMed Web of Science ®Google Scholar
• Gajendran M, Loganathan P, Jimenez G, et al. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65(12):100851.
   PubMed Web of Science ®Google Scholar
• Tripathi K, Feuerstein JD. New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance. Drugs Context. 2019;8:212572. doi:10.7573/dic.212572
   PubMedGoogle Scholar
• Pagnini C, Pizarro TT, Cominelli F. Novel pharmacological therapy in inflammatory bowel diseases: beyond anti-tumor necrosis factor. Front Pharmacol. 2019;10:671.
   PubMed Web of Science ®Google Scholar
• Shi H, Zhao X, Gao J, et al. Acid-resistant ROS-responsive hyperbranched polythioether micelles for ulcerative colitis therapy. Chinese Chem Letters. 2020;31(12):3102–3106. doi:10.1016/j.cclet.2020.03.039
   Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–124.
   PubMed Web of Science ®Google Scholar
• Chen F, Liu Q, Xiong Y, Xu L. Current strategies and potential prospects of nanomedicine-mediated therapy in inflammatory bowel disease. Int J Nanomedicine. 2021;16:4225–4237. doi:10.2147/IJN.S310952
   PubMed Web of Science ®Google Scholar
• Yu W, Shevtsov M, Chen X, Gao H. Advances in aggregatable nanoparticles for tumor-targeted drug delivery. Chinese Chem Letters. 2020;31(6):1366–1374. doi:10.1016/j.cclet.2020.02.036
   Web of Science ®Google Scholar
• Lonn P, Kacsinta AD, Cui XS, et al. Enhancing endosomal escape for intracellular delivery of macromolecular biologic therapeutics. Sci Rep. 2016;6:32301. doi:10.1038/srep32301
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu J, Choi HH, et al. Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer. Nat Commun. 2018;9(1):4718.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu Y, Li Y, et al. Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer. Nat Nanotechnol. 2019;14(4):388–397. doi:10.1038/s41565-019-0381-6
   PubMed Web of Science ®Google Scholar
• Chen J, Li J, Zhou J, et al. Metal-phenolic coatings as a platform to trigger endosomal escape of nanoparticles. ACS Nano. 2019;13(10):11653–11664. doi:10.1021/acsnano.9b05521
   PubMed Web of Science ®Google Scholar
• Qin Y, Guo Q, Wu S, et al. LHRH/TAT dual peptides-conjugated polymeric vesicles for PTT enhanced chemotherapy to overcome hepatocellular carcinoma. Chinese Chem Letters. 2020;31(12):3121–3126. doi:10.1016/j.cclet.2020.06.023
   Web of Science ®Google Scholar
• Hong SK, Maltz BE, Coburn LA, et al. Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity. Inflamm Bowel Dis. 2010;16(1):105–111. doi:10.1002/ibd.21035
   PubMed Web of Science ®Google Scholar
• Coburn LA, Gong X, Singh K, et al. L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS One. 2012;7(3):e33546. doi:10.1371/journal.pone.0033546
   PubMed Web of Science ®Google Scholar
• Andrade MER, Santos RDGCD, Soares ADN, et al. Pretreatment and treatment with L-arginine attenuate weight loss and bacterial translocation in dextran sulfate sodium colitis. JPEN J Parenter Enteral Nutr. 2016;40(8):1131–1139. doi:10.1177/0148607115581374
   PubMed Web of Science ®Google Scholar
• Singh K, Gobert AP, Coburn LA, et al. Dietary arginine regulates severity of experimental colitis and affects the colonic microbiome. Front Cell Infect Microbiol. 2019;9:66. doi:10.3389/fcimb.2019.00066
   PubMed Web of Science ®Google Scholar
• Baier J, Gansbauer M, Giessler C, et al. Arginase impedes the resolution of colitis by altering the microbiome and metabolome. J Clin Invest. 2020;130(11):5703–5720. doi:10.1172/JCI126923
   PubMed Web of Science ®Google Scholar
• Chen Y, Park J, Joe Y, et al. Pterostilbene 4’-beta-glucoside protects against dss-induced colitis via induction of tristetraprolin. Oxid Med Cell Longev. 2017;2017:9427583. doi:10.1155/2017/9427583
   PubMed Web of Science ®Google Scholar
• Shi L, Liu Q, Tang J-H, Wen -J-J, Li C. Protective effects of pterostilbene on ulcerative colitis in rats via suppressing NF-κB pathway and activating PPAR-γ. Eur J Inflamm. 2019;17:2058739219840152.
   Web of Science ®Google Scholar
• Laroui H, Sitaraman SV, Merlin D. A method to target bioactive compounds to specific regions of the gastrointestinal tract: double gavage using polysaccharide hydrogels. Protocol Exchange. 2009.
   Google Scholar
• Laroui H, Dalmasso G, Nguyen HT, Yan Y, Sitaraman SV, Merlin D. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Gastroenterology. 2010;138(3):843–53e1-2. doi:10.1053/j.gastro.2009.11.003
   PubMed Web of Science ®Google Scholar
• Xiao B, Zhang Z, Viennois E, et al. Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation. Theranostics. 2016;6(12):2250–2266. doi:10.7150/thno.15710
   PubMed Web of Science ®Google Scholar
• Xiao B, Viennois E, Chen Q, et al. Silencing of intestinal glycoprotein CD98 by orally targeted nanoparticles enhances chemosensitization of colon cancer. ACS Nano. 2018;12(6):5253–5265. doi:10.1021/acsnano.7b08499
   PubMed Web of Science ®Google Scholar
• Dou YX, Zhou JT, Wang TT, et al. Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis. Int J Nanomedicine. 2018;13:5887–5907. doi:10.2147/IJN.S174146
   PubMed Web of Science ®Google Scholar
• Yang M, Zhang F, Yang C, et al. Oral targeted delivery by nanoparticles enhances efficacy of an HSP90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer. J Crohns Colitis. 2020;14(1):130–141. doi:10.1093/ecco-jcc/jjz113
   PubMed Web of Science ®Google Scholar
• Tian H, He Z, Sun C, et al. Uniform core-shell nanoparticles with thiolated hyaluronic acid coating to enhance oral delivery of insulin. Adv Healthc Mater. 2018;7(17):e1800285. doi:10.1002/adhm.201800285
   PubMed Web of Science ®Google Scholar
• Deng J, Wu Z, Zhao Z, et al. Berberine-loaded nanostructured lipid carriers enhance the treatment of ulcerative colitis. Int J Nanomedicine. 2020;15:3937–3951. doi:10.2147/IJN.S247406
   PubMed Web of Science ®Google Scholar
• Xiao YT, Yan WH, Cao Y, Yan JK, Cai W. Neutralization of IL-6 and TNF-alpha ameliorates intestinal permeability in DSS-induced colitis. Cytokine. 2016;83:189–192. doi:10.1016/j.cyto.2016.04.012
   PubMed Web of Science ®Google Scholar
• Chen L, You Q, Hu L, et al. The antioxidant procyanidin reduces reactive oxygen species signaling in macrophages and ameliorates experimental colitis in mice. Front Immunol. 2017;8:1910. doi:10.3389/fimmu.2017.01910
   PubMed Web of Science ®Google Scholar
• Naeem M, Bae J, Oshi MA, et al. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit((R)) FS30D/PLGA nanoparticles ameliorates murine experimental colitis. Int J Nanomedicine. 2018;13:1225–1240. doi:10.2147/IJN.S157566
   PubMed Web of Science ®Google Scholar
• Sun Y, Duan B, Chen H, Xu X, Novel A. Strategy for treating inflammatory bowel disease by targeting delivery of methotrexate through glucan particles. Adv Healthc Mater. 2020;9(6):e1901805.
   PubMed Web of Science ®Google Scholar
• Ji W, Zhang T, Lu Z, Shen J, Xiao Z, Zhang X. Synthesis and characterization of novel biocompatible nanocapsules encapsulated lily fragrance. Chinese Chem Letters. 2019;30(3):739–742. doi:10.1016/j.cclet.2018.09.008
   Web of Science ®Google Scholar
• Martens TF, Remaut K, Demeester J, De Smedt SC, Braeckmans K. Intracellular delivery of nanomaterials: how to catch endosomal escape in the act. Nano Today. 2014;9(3):344–364. doi:10.1016/j.nantod.2014.04.011
   Web of Science ®Google Scholar
• Smith SA, Selby LI, Johnston APR, Such GK. The endosomal escape of nanoparticles: toward more efficient cellular delivery. Bioconjug Chem. 2019;30(2):263–272. doi:10.1021/acs.bioconjchem.8b00732
   PubMed Web of Science ®Google Scholar
• Cupic KI, Rennick JJ, Johnston AP, Such GK. Controlling endosomal escape using nanoparticle composition: current progress and future perspectives. Nanomedicine. 2019;14:215–223. doi:10.2217/nnm-2018-0326
   PubMed Web of Science ®Google Scholar
• Ahmad A, Khan JM, Haque S. Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles. Biochimie. 2019;160:61–75.
   PubMed Web of Science ®Google Scholar
• Zheng P, Liu Y, Chen J, Xu W, Li G, Ding J. Targeted pH-responsive polyion complex micelle for controlled intracellular drug delivery. Chinese Chem Letters. 2020;31(5):1178–1182. doi:10.1016/j.cclet.2019.12.001
   Web of Science ®Google Scholar
• Vong LB, Yoshitomi T, Morikawa K, Saito S, Matsui H, Nagasaki Y. Oral nanotherapeutics: effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced colitis. J Gastroenterol. 2014;49(5):806–813. doi:10.1007/s00535-013-0836-8
   PubMed Web of Science ®Google Scholar
• Wang W, Liu P, Hao C, Wu L, Wan W, Mao X. Neoagaro-oligosaccharide monomers inhibit inflammation in LPS-stimulated macrophages through suppression of MAPK and NF-kappaB pathways. Sci Rep. 2017;7:44252. doi:10.1038/srep44252
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao H, Lv K, et al. Pterostilbene Ameliorates dss-induced intestinal epithelial barrier loss in mice via suppression of the NF-kappaB-mediated MLCK-MLC signaling pathway. J Agric Food Chem. 2021;69(13):3871–3878.
   PubMed Web of Science ®Google Scholar
• Yashiro T, Yura S, Tobita A, Toyoda Y, Kasakura K, Nishiyama C. Pterostilbene reduces colonic inflammation by suppressing dendritic cell activation and promoting regulatory T cell development. FASEB J. 2020;34(11):14810–14819. doi:10.1096/fj.202001502R
   PubMed Web of Science ®Google Scholar
• Zhang M, Merlin D. Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis. Inflamm Bowel Dis. 2018;24(7):1401–1415.
   PubMed Web of Science ®Google Scholar
• Duan B, Li M, Sun Y, Zou S, Xu X. Orally delivered antisense oligodeoxyribonucleotides of TNF-alpha via polysaccharide-based nanocomposites targeting intestinal inflammation. Adv Healthc Mater. 2019;8(5):e1801389. doi:10.1002/adhm.201801389
   PubMed Web of Science ®Google Scholar
• Yang M, Zhang Y, Ma Y, et al. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. J Bio-X Res. 2020;3(4):157–173.
   Google Scholar
• Meng Q, Cooney M, Yepuri N, Cooney RN. L-arginine attenuates Interleukin-1beta (IL-1beta) induced Nuclear Factor Kappa-Beta (NF-kappaB) activation in Caco-2 cells. PLoS One. 2017;12(3):e0174441. doi:10.1371/journal.pone.0174441
   PubMed Web of Science ®Google Scholar
• Qiu Y, Yang X, Wang L, Gao K, Jiang Z. L-arginine inhibited inflammatory response and oxidative stress induced by lipopolysaccharide via arginase-1 signaling in IPEC-J2 cells. Int J Mol Sci. 2019;20:7. doi:10.3390/ijms20071800
   Web of Science ®Google Scholar
• Andrade MER, Barros P, Menta P, et al. Arginine supplementation reduces colonic injury, inflammation and oxidative stress of DSS-induced colitis in mice. J Funct Foods. 2019;52:360–369. doi:10.1016/j.jff.2018.11.019
   Web of Science ®Google Scholar
• Krzystek-Korpacka M, Fleszar MG, Bednarz-Misa I, et al. Transcriptional and metabolomic analysis of L-arginine/nitric oxide pathway in inflammatory bowel disease and its association with local inflammatory and angiogenic response: preliminary findings. Int J Mol Sci. 2020;21:5. doi:10.3390/ijms21051641
   Web of Science ®Google Scholar